Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - bioRxiv, 2021 - biorxiv.org
In 2020, two mRNA-based vaccines, encoding the full length of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for control of …
syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for control of …
[PDF][PDF] Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 1 receptor-binding domain 2
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - academia.edu
8Correspondence should be addressed to 26 Ken J. Ishii kenishii@ ims. u-tokyo. ac. jp, or
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …
[PDF][PDF] Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 1 receptor-binding domain 2
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - scholar.archive.org
8Correspondence should be addressed to 26 Ken J. Ishii kenishii@ ims. u-tokyo. ac. jp, or
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …
Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - (No Title), 2021 - cir.nii.ac.jp
抄録< jats: p> In 2020, two mRNA-based vaccines, encoding the full length of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for …
respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for …
[HTML][HTML] Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - 2021 - europepmc.org
In 2020, two mRNA-based vaccines, encoding the full length of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for control of …
syndrome coronavirus 2 (SARS-CoV-2) spike protein, have been introduced for control of …
[PDF][PDF] Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 1 receptor-binding domain 2
K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki… - academia.edu
8Correspondence should be addressed to 26 Ken J. Ishii kenishii@ ims. u-tokyo. ac. jp, or
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …
27 Yoshihiro Kawaoka kawaoka@ ims. u-tokyo. ac. jp 28 Fumihiko Takeshita takeshita …